Alembic Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
ALEMBICLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts less than Nifty Microcap 250 and 2.9 pts less than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Alembic Limited reported consolidated revenue of Rs 23,999 lakhs for FY26, up 8.2% from Rs 22,189 lakhs in FY25. Net profit after tax including share of associate grew marginally to Rs 31,738 lakhs from Rs 31,068 lakhs. However, standalone net profit declined 12.3% to Rs 12,454 lakhs from Rs 14,195 lakhs. The company operates in two segments - Active Pharmaceutical Ingredients (API) and Real Estate, with Real Estate contributing ~81% of revenue. The Board recommended dividend of Rs 2.40 per share (120%) at same level as previous year. Auditors issued unmodified opinion on both consolidated and standalone results. An emphasis of matter was raised regarding a disputed electricity duty matter where Rs 2,052.13 lakhs provision has been made and Rs 3,500 lakhs deposited with Supreme Court.
Revenue grew modestly but standalone profitability declined. The electricity duty dispute remains a contingent liability requiring shareholder attention. Positive operating cash flows of Rs 12,007 lakhs indicate strong cash generation. The unchanged dividend reflects management confidence despite profit pressure.